Nkarta (NKTX) Enterprise Value (2019 - 2026)
Nkarta's quarterly Enterprise Value came in at -$469.8 million in Q1 2026, down 76.93% year-on-year from -$2.0 billion in Q1 2025, and down 70.04% quarter-over-quarter from -$276.3 million in Q4 2025.
Nkarta has reported Enterprise Value for 8 years, with the latest figure at -$469.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 76.93% year-over-year to -$469.8 million; the trailing twelve-month figure through Mar 2026 stood at -$469.8 million (down 76.93% YoY), and the FY2025 full-year result was -$276.3 million, down 3.34% from the prior year.
- Enterprise Value for Q1 2026 stood at -$469.8 million, down from -$276.3 million in the prior quarter.
- The five-year high for Enterprise Value was -$217.0 million in Q1 2022, with the low at -$570.3 million in Q2 2025.
- Average Enterprise Value over 5 years is -$334.1 million, with a median of -$283.1 million recorded in 2024.
- Year-over-year, Enterprise Value soared 39.3% in 2025 and plunged 76.93% in 2026.
- Tracing NKTX's Enterprise Value over 5 years: stood at -$352.1 million in 2022, then climbed by 29.52% to -$248.2 million in 2023, then declined by 7.72% to -$267.4 million in 2024, then fell by 3.34% to -$276.3 million in 2025, then plunged by 70.04% to -$469.8 million in 2026.
- The last three Enterprise Value figures came in at -$469.8 million (Q1 2026), -$276.3 million (Q4 2025), and -$282.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Nkarta | 232.80 Mn | 232.80 Mn | - | -469.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -469.77 Mn |
| Dec 31, 2025 | -276.28 Mn |
| Sep 30, 2025 | -282.33 Mn |
| Jun 30, 2025 | -570.27 Mn |
| Mar 31, 2025 | -265.51 Mn |
| Dec 31, 2024 | -267.35 Mn |
| Sep 30, 2024 | -283.06 Mn |
| Jun 30, 2024 | -324.82 Mn |
| Mar 31, 2024 | -437.39 Mn |
| Dec 31, 2023 | -248.19 Mn |
| Sep 30, 2023 | -275.61 Mn |
| Jun 30, 2023 | -280.75 Mn |
| Mar 31, 2023 | -323.34 Mn |
| Dec 31, 2022 | -352.14 Mn |
| Sep 30, 2022 | -392.36 Mn |
| Jun 30, 2022 | -412.95 Mn |
| Mar 31, 2022 | -216.96 Mn |
| Dec 31, 2021 | -238.09 Mn |
| Sep 30, 2021 | -257.70 Mn |
| Jun 30, 2021 | -279.80 Mn |
| Mar 31, 2021 | -299.26 Mn |
| Dec 31, 2020 | -314.91 Mn |
| Sep 30, 2020 | -329.76 Mn |
| Jun 30, 2020 | -21.65 Mn |
| Mar 31, 2020 | -16.51 Mn |
| Dec 31, 2019 | -36.99 Mn |
| Sep 30, 2019 | -39.10 Mn |
| Jun 30, 2019 | -5.91 Mn |